Original Source(s)
Related Content
FDA Approves Baxdrostat for Resistant Hypertension
Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.
May 18, 2026
-
2 min
What RVO May Reveal About Systemic Health
TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.
May 14, 2026
-
3 min